Web implementation of two risk prediction models for incidence or progression of early chronic kidney disease in 5 years for people with type 2 diabetes.
Early chronic kidney disease is defined as progression to micro- or macro-albuminuria (i.e. progression of urinary albumin/creatinine ratio to above 3.4 mg/mmol or 33.9 mg/mmol (or 30mg/g or 300 mg/g), respectively), doubling of serum creatinine, end-stage renal disease (i.e. an estimated glomerular filtration rate smaller than 15 ml/min per 1.73 m2), or need for renal replacement therapy.
The risk calculator is developed for people who are 55 years or older, have diabetes mellitus type 2 and are normo- or microalbuminuric.
Laboratory model incorporating only information on renal laboratory characteristics.
Clinical model incorporating renal, demographic and clinical characteristics.
The clinical model incorporates additional information and therefore, the two models may give different estimates of the absolute risk of early diabetic chronic kidney disease in 5 years.
This is the amount of albumin excreted in urine, normalized to creatinine. Both parameters can be measured in urine in a standard laboratory. If your ratio is larger than 33.4 mg/mmol (or 300 mg/g), you already have advanced kidney disease.
Urinary albumin-creatinine ratio is sometimes also given in mg/g.
You can convert urinary albumin/creatinine ratio in mg/g to mg/mmol by multiplying it with 0.113.
This parameter is usually provided together with creatinine in a standard laboratory readout. Since the normal value is around 100, it can also be seen as % of kidney function.
Early diabetic chronic kidney disease is defined as
progression to micro- or macro-albuminuria, i.e. progression of urinary albumin/creatinine ratio to above 3.4 mg/mmol or 33.9 mg/mmol (30 mg/g or 300 mg/g), respectively, or
doubling of serum creatinine from now to in 5 years, or
end-stage renal disease, i.e. an estimated glomerular filtration rate smaller than 15 ml/min per 1.73m2, or